Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Kirin Brewery presents new inhibitors of Bcl-2/Bcl-xL with utility in cancer therapy

Jan. 7, 2004

Pharmion submits Vidaza NDA

Jan. 7, 2004

Positive proof of concept results for SUDCA

Jan. 5, 2004

CTX granted for phase IIa trial of ATL-104 for mucositis

Jan. 5, 2004

First patient enrolled in trial of dendritic cell vaccine for melanoma

Jan. 5, 2004

Tributyrin induces apoptosis of leukemia cell lines

Dec. 30, 2003

Potential clinical benefits of CAI in ovarian cancer

Dec. 30, 2003

European orphan drug designation for gimatecan for glioma

Dec. 30, 2003

Enrollment completed in phase IIa study of PCK-3145

Dec. 30, 2003

GTI-2501 enters phase II

Dec. 30, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 4, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...